In The Media
June 2009 - Year of the Compound - The Scientist
by Elie Dolgin
Will a novel codevelopment model open up China's drug discovery platform?
Read Full Article
May 2009 - The Future of Ancient Cures - Scientific American
Turning traditional Chinese medicine modern and leading the way for new drugs
by Mara Hvistendahl
Wolfberry, licorice and caterpillar fungus. Such substances don't sound like the makings of modern medicine, but they might soon be just that. China's current five-year plan lists the "modernization" of traditional Chinese medicine (TCM) as one of 12 focal points, allotting 1 billion yuan ($146 million) for the task. The goal is to move away from philosophies like yin-yang and meridian theory and toward science-by introducing randomized, double-blind, placebo controlled trials...
Read Full Article
6 February 2009 - HUYA Looks to Ride the Wave of Chinese Innovation - SCRIP World Pharmaceutical News
The pursuit of cost-effective innovation may have led many multinationals to build up their R&D activities in China recently, but one entrepreneur spotted the vast potential of the country's research expertise several years ago. HUYA Bioscience International's founder, president and CEO Dr Mireille Gingras, talks to Scrip's Asia editor Ian Haydock...
Read Full Article
8 January 2009 - HUYA Bioscience Taps into China for Novel Drug Candidates - Xconomy.com
HUYA sources novel drug candidates to meet the growing needs of big pharma drug pipelines, interview with Mireille Gingras, CEO HUYA Bioscience
If there was an "ah-ha" moment for Huya Bioscience International, it occurred in 2004, when founder Mireille Gingras was working as a consultant for mid-size biotech companies...
Read Full Article
13 November 2008 - HUYA: A Conduit Between Chinese Pharma and US Clinical Trials - PharmaWeek
HUYA's innovative Integrated Co-development Model for drug development is validated with Chinese-based Phase I clinical trial results on Chidamide (HBI-8000), a novel histone deacetylase (HDAC) inhibitor of the benzamide class.
Read Full Article
October 2008 - Drug discovery in China - Nature Reviews
Organizations worldwide have shown growing interest in China as a location for drug discovery and development. This month, we feature two people closely involved in harnessing the therapeutic potential of compounds discovered in China.
Read Full Article
21 August 2008 - Huya CEO Mireille Gingras On Partnering To Develop Chinese Compounds In The West - PharmAsia News
Read Full Article
1 August 2008 - GEN Reviews BIO 2008 - Genetic Engineering News
GEN Reviews BIO 2008: Tips for Doing Business in China and India Risks, IP, Opportunities, and Approaches Are Morphing at Breakneck Speed
Read Full Article
21 July 2008 - Huya Targeting China to Accelerate Drug Production - San Diego Business Journal
Risk reduction has always been an attractive business practice, but it has an especially sweet-sounding ring for drug firms looking to bring new medicines onto the market.
Read Full Article